SRZN CIK: 1824893

Surrozen, Inc./DE

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−48.8
FY22:
−44.1
FY23:
−40.4
FY24:
−17.6
FY25:
−30.2
Change from FY21 to FY25
millions USD
FY21:
−77.7
FY22:
38.3
FY23:
51.7
FY24:
−0.03
FY25:
−0.13
Change from FY21 to FY25
millions USD
FY21:
125
FY22:
−2.57
FY23:
0.28
FY24:
16.2
FY25:
85.1
millions USD
FY21:
−1.89
FY22:
−8.40
FY23:
11.6
FY24:
−1.48
FY25:
54.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−50.1
FY22:
−44.9
FY23:
−40.8
FY24:
−17.7
FY25:
−30.4

All amounts in millions USD Data source:SEC EDGAR